Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Share
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Trivariate Research CEO Adam Parker and Nicole Webb, senior vice president and financial advisor at Wealth Enhancement Group, join ‘Closing Bell’ to discuss their market outlook for 2024, expectations from the Fed, and more. 19:36 Tue, Jan 9 20243:35 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Boeing CEO Dave Calhoun joins ‘The Exchange’ to discuss the Alaska Airlines incident, how the company is addressing this, and more. 04:00 Wed, Jan 10 20241:22 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fred Thiel, Marathon Digital CEO and Mike Belshe, Bitgo CEO, joins ‘Closing Bell Overtime’ to talk the kick off of spot bitcoin ETF trading after SEC approval.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email The Australian government has advised its citizens not to travel to Hong Kong, and to reconsider their need to remain in Hong Kong, due to uncertainties surrounding the new national security law there. CNBC’s Will Koulouris reports. 01:27 Thu, Jul 9 202012:26…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Brent Thill, Jefferies managing director, joins ‘TechCheck’ to discuss companies trimming spending on cloud computing, Amazon’s positioning in the second part of 2023 and e-commerce spending continuing to gain momentum. 03:55 Tue, Dec 27 202211:56 AM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Power Lunch Michael Kantrowitz, chief investment strategist at Piper Sandler, joins ‘Power Lunch’ to discuss why he’s still bearish on the market and more. 06:36 12 minutes ago